PART I . As used in this Annual Report, unless the context indicates or otherwise requires, ARS, ARS Pharma, the company, we, us, our, and other similar terms refer to ARS Pharmaceuticals, Inc., a Delaware corporation and its consolidated subsidiaries. neffy and EURneffy are trademarks of ours that we use in this Annual Report. This Annual Report also includes trademarks, trade names, and service marks that are the property of other organizations. Solely for convenience, our trademarks and trade...
Q2 FY2026 — expected 2026-09-18
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-09 | 2025-12-31 | 0001193125-26-097478 | EDGAR | 112K words |
| 2025-03-20 | 2024-12-31 | 0000950170-25-042320 | EDGAR | — |
| 2024-03-21 | 2023-12-31 | 0000950170-24-034689 | EDGAR | — |
| 2023-03-23 | 2022-12-31 | 0000950170-23-009491 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0000950170-22-005202 | EDGAR | — |
| 2021-03-29 | 2020-12-31 | 0001193125-21-098283 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-10 | 2025-09-30 | 0001193125-25-273111 | EDGAR | 81K words |
| 2025-08-13 | 2025-06-30 | 0000950170-25-107618 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0000950170-25-070900 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0000950170-24-125924 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0000950170-24-091776 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0000950170-24-056967 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0000950170-23-061996 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0000950170-23-041310 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0000950170-23-021997 | EDGAR | — |
| 2022-11-02 | 2022-09-30 | 0000950170-22-021234 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0000950170-22-016840 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0000950170-22-009694 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-17 | 0001193125-26-307773 | EDGAR | — |
| 2026-03-09 | 0001193125-26-097467 | EDGAR | 4K words |
| 2025-11-10 | 0001193125-25-273107 | EDGAR | — |
| 2025-09-29 | 0001193125-25-223228 | EDGAR | — |
| 2025-08-28 | 0001193125-25-190202 | EDGAR | — |
| 2025-08-13 | 0000950170-25-107617 | EDGAR | — |
| 2025-06-26 | 0001193125-25-148922 | EDGAR | — |
| 2025-05-14 | 0000950170-25-070899 | EDGAR | — |
| 2025-05-02 | 0001193125-25-110696 | EDGAR | — |
| 2025-03-20 | 0000950170-25-042317 | EDGAR | — |
94 total filings indexed. 66 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001671858 |
| Ticker | SPRY |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.ars-pharma.com |
| Listed | 2022-11-09 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/SPRY (~200 tokens, structured JSON with cryptographic provenance)